To treat pelvic nodes or not: could the greater testicular scatter dose from whole pelvic fields confound results of prostate cancer trials?
King
Christopher R
CR
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
Kapp
Daniel S
DS
D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology / Q000528:radiation effects*; D008297:Male; D010388:Pelvis / Q000528:radiation effects; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D013737:Testis / Q000528:radiation effects